Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHilton Foods Regulatory News (HFG)

Share Price Information for Hilton Foods (HFG)

Share Price is delayed by 15 minutes
Get Live Data
521.00    -2.50 (-0.48%)
Bid:
520.00
Ask:
520.50
Spread: 0.50 (0.096%)
Market Cap: £468.67m
HFG Live PriceLast checked at - London Stock Exchange

Intraday Hilton Foods Share Chart

Directorate change

16 Jun 2026 07:00

RNS Number : 3829I
Hilton Food Group PLC
16 June 2026
 

16 June 2026

Hilton Food Group plc

Directorate Change

Mark Clare appointed Chair of Hilton Food Group plc

Hilton Food Group plc (the "Company") is pleased to announce that Mark Clare has been appointed as Independent Non-executive Chair of the Company's board ("Board") with effect from 1 July 2026. Following its announcement on 31 March 2026, the Company is now able to confirm that Mark Allen, currently Executive Chair, will assume the role of Group Chief Executive on 1 July 2026.

Mark Clare has extensive public listed company experience as a Chief Executive, Non-executive Director, Senior Independent Director and Board Chair. He is currently a Non-executive Director and Chair of the Remuneration Committee at Wickes Group Plc and a Non-executive Director at Drax Group plc. Mark was Chair of Grainger plc from 2017 to February 2026, Chair (designate) at Aggreko plc (now Aggreko Ltd) from October 2020 to August 2021, and Chair of Ricardo plc from 2022 to 2025. He was Senior Independent Director at United Utilities Group plc from 2013 to 2022, Senior Independent Director at Ladbroke's Coral Group plc from 2016 until 2018, and Non-executive Director and Audit Committee Chair at BAA plc from 2001 until 2006.

Mark's executive career included Chief Executive for Barratt Developments plc from 2006 until 2015; Managing Director of Centrica's retail subsidiary British Gas from 2002 to 2006; and CFO of Centrica plc from 1997 to 2002.

Mark Allen, Executive Chair, commented:

"Mark brings fantastic public company and commercial experience to our Board. He has been successful at the most senior executive and non-executive levels in a distinguished career. The Board and I are very much looking forward to working with him. In the role of Group Chief Executive Officer, I will value the broad and deep experience he will be able to bring to bear as Chair of the Board, especially as we implement our clear plan arising from our strategic review to focus the business on its core capabilities and deliver sustainable long-term growth."

Mark Clare, Chair (designate), commented:

"I am delighted to be joining the Board. Hilton Foods is at a pivotal stage in its evolution as it focuses on its strategy built around three growth levers, disciplined capital allocation and updated medium-term targets. I am excited to have the opportunity to lead the Board as we seek to maximise the business' core, enhance its mix and expand geographically."

There is no further information to be disclosed in respect of Mark Clare under paragraphs (1) to (6) of Listing Rule 6.4.8.

 

END

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/204 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) and has been authorised for release by Robin Miller Group General Counsel and Company Secretary.

 

Enquiries:

Hilton Food Group plc Tel: +44 (0) 1480 387214

Martyn Espley, Investor Relations Director Email: investorrelations@hiltonfoodgroup.com

Headland Consultancy Tel: +44 (0) 20 3805 4822

Ed Young Email: hiltonfood@headlandconsultancy.com

Will Smith

 

Remuneration Disclosure:

As Group Chief Executive Officer Mark Allen will receive an annual salary of £850,000. He will be eligible for an annual bonus of 150% of base salary and Long Term Incentive Plan ("LTIP") awards of 175% of salary. Mark will be eligible for a bonus and will receive LTIP awards in respect of 2026. He will receive other benefits consistent with the Company's Directors' Remuneration Policy in force from time to time. Further detail will be set out in the 2026 Directors' Remuneration Report. Mark Clare will receive an annual fee of £250,000 as Chair.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGMVRKGGVZM
Date   Source Headline
16th Jun 20267:00 amRNSDirectorate change
27th May 20268:22 amRNSDirectorate change
19th May 20264:00 pmRNSResult of AGM
19th May 20267:00 amRNSAGM Trading Update
28th Apr 20264:54 pmRNSHolding(s) in Company
16th Apr 20266:01 pmRNSAnnual Financial Report & Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20263:53 pmRNSHolding(s) in Company
31st Mar 20267:01 amRNSDirectorate change
31st Mar 20267:00 amRNSPreliminary Results
2nd Feb 20267:00 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNS2025 Full Year Trading Update
8th Jan 20267:00 amRNSBoard and Senior Leadership Changes
2nd Jan 202612:25 pmRNSTotal Voting Rights
2nd Jan 202612:19 pmRNSBlock listing Interim Review
2nd Dec 20252:14 pmRNSNotification of Dealing Form
25th Nov 20257:00 amRNSDirectorate Change
13th Nov 20254:02 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
23rd Oct 20257:00 amRNSNotification of major holdings
10th Oct 20252:39 pmRNSDirector/PDMR Shareholding
1st Oct 20256:30 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSSale of Fairfax Meadow Europe Limited
3rd Sep 20257:00 amRNSInterim Results
6th Aug 20253:19 pmRNSHolding(s) in Company
5th Aug 20252:43 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSStrategic External Investment
14th Jul 20252:50 pmRNSAdditional Listing
2nd Jul 20259:50 amRNSBlock listing Interim Review
20th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20253:26 pmRNSHolding(s) in Company
27th May 20252:22 pmRNSDirector/PDMR Shareholding
20th May 20253:57 pmRNSResult of AGM
20th May 20257:00 amRNSBoard Changes
20th May 20257:00 amRNSAGM Trading Update
13th May 20253:44 pmRNSDirector/PDMR Shareholding
6th May 20253:15 pmRNSTotal Voting Rights
28th Apr 20259:36 amRNSHolding(s) in Company
23rd Apr 20255:16 pmRNSDirector/PDMR Shareholding
22nd Apr 20251:56 pmRNSAnnual Financial Report
8th Apr 20253:48 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPreliminary Results
6th Mar 20257:00 amRNSChange in Senior Independent Director
6th Mar 20257:00 amRNSHILTON FOODS SIGNS JOINT VENTURE WITH NADEC
26th Feb 20254:14 pmRNSHolding(s) in Company
29th Jan 20253:21 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSFull Year Trading Update
2nd Jan 202511:51 amRNSBlock listing Interim Review
2nd Jan 202511:47 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.